Oxolife
Founded Year
2013Stage
Grant | AliveTotal Raised
$8.21MLast Raised
$2.55M | 3 mos agoAbout Oxolife
Oxolife develops a drug to increase embryo implantation in female fertility treatment. It aims to improve female fertility and women's health by identifying and developing new treatments for women's reproductive health. The company was founded in 2013 and is based in Barcelona, Spain.
Missing: Oxolife's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Oxolife's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Expert Collections containing Oxolife
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Oxolife is included in 2 Expert Collections, including Biopharma Tech.
Biopharma Tech
5,241 items
Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.
Women's Health & Wellness
1,487 items
Startups focused on providing products and services catering to women's health and wellbeing.
Oxolife Patents
Oxolife has filed 2 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
7/21/2014 | 8/13/2019 | Fertility medicine, Fertility, Diabetes, Human female endocrine system, Rare diseases | Grant |
Application Date | 7/21/2014 |
|---|---|
Grant Date | 8/13/2019 |
Title | |
Related Topics | Fertility medicine, Fertility, Diabetes, Human female endocrine system, Rare diseases |
Status | Grant |
Latest Oxolife News
Dec 13, 2022
13/12/2022 Nota de prensa OXOLIFE RECEIVES A 2.4M€ GRANT TO DEVELOP A NEW TREATMENT FOR INFERTILITY RELATED TO POLYCYSTIC OVARIAN SÍNDROME Oxolife, the Women’s Reproductive Health R&D biotech, has been awarded with a 2.4M€ grant from the Spanish Science and Innovation Ministry (Plan Estatal de Investigación Científica) to develop a new treatment for infertility related… La entrada Oxolife receives a 2.4M€ grant to develop a new treatment for infertility related to polycystic ovarian síndrome se publicó primero en Webcapitalriesgo.
Oxolife Frequently Asked Questions (FAQ)
When was Oxolife founded?
Oxolife was founded in 2013.
Where is Oxolife's headquarters?
Oxolife's headquarters is located at C/Nou 46 ‘Sant Quirze del Vallès, Barcelona.
What is Oxolife's latest funding round?
Oxolife's latest funding round is Grant.
How much did Oxolife raise?
Oxolife raised a total of $8.21M.
Who are the investors of Oxolife?
Investors of Oxolife include Ministry of Science and Innovation, Centro para el Desarrollo Tecnologico Industrial, Inveready, BStartup, Capital Cell and 4 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.